等待開盤 07-21 09:30:00 美东时间
-0.060
-0.35%
UBS analyst Ami Probandt maintains Independence Realty Trust (NYSE:IRT) with a Buy and lowers the price target from $24 to $21.
07-15 22:41
WOODCLIFF LAKE, N.J., July 10, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset...
07-11 04:15
WOODCLIFF LAKE, N.J., June 20, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT) today announced that management is scheduled to attend the Northland Growth Conference 2025 on Wednesday, ...
06-20 19:00
WAVES新浪潮2025邀你一起走向中国创投的「新纪元」。 这是属于中国创投的新纪元。当下的中国创投市场,既是周期筑底的转折点,也是结构性转型的深化期。在政策...
06-20 14:58
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从112美元升至120美元</p> <p>• 巴克莱:维持Karyopharm Therapeutics(KPTI)"超配"评级,目标价从5美
05-14 08:48
潜在涨幅754.7%!HC Wainwright & Co.:Alector获机构升目标价至10美元,维持"买入"评级
05-10 10:00
Barclays analyst Richard Hightower maintains Independence Realty Trust (NYSE:IRT) with a Equal-Weight and raises the price target from $21 to $22.
05-09 21:03
The latest announcement is out from Independence Realty ( ($IRT) ). Independenc...
05-06 04:58
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117736711687032832.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 杰富瑞:上调内克塔治疗(NKTR)评级至"买入",目标价从1美元升至2美元</p> <p>• Roth MKM:维持Lovesac Co.(LOVE)"买入"评级,目标价从22美元升至28美元</p> <p>• Macq
04-14 07:05
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Pacira BioSciences(PCRX)"买入"评级,目标价从48美元升至65美元</p> <p>• 瑞穗:上调Amylyx Pharmaceuticals(AM
04-09 08:50